Osiris Begins Phase II Clinical Trial With Adult Stem Cell Therapy for the Treatment of Heart Attack
Osiris Therapeutics begins Phase II clinical trials for its Prochymal adult stem cell therapy in the regeneration of cardiac tissue following myocardial infarction.